Invenio Imaging specializes in advanced imaging solutions designed to enhance the precision and effectiveness of brain tumor surgeries. The company's flagship product, NIO Glioma Reveal, leverages deep learning algorithms to help neurosurgeons identify cancer infiltration areas during surgery, significantly improving intraoperative decision-making. Operating primarily in the healthcare and medical technology sectors, Invenio Imaging serves neurosurgeons and medical researchers in the European Union and the United States. The business model revolves around the sale and licensing of its imaging systems and software, generating revenue through product sales and research collaborations. The NIO Imaging System delivers high-quality images in under three minutes, facilitating real-time analysis and reducing operating room time. Additionally, the NIO Slide technology allows for sample preparation without staining or sectioning, enabling seamless integration with existing IT infrastructures via a vendor-neutral DICOM interface.

Keywords: brain tumor surgery, cancer detection, deep learning, neurosurgeons, intraoperative imaging, digital pathology, real-time analysis, medical technology, healthcare, imaging systems.